AMO-01 to Treat Adolescents and Adults With Phelan-McDermid Syndrome (PMS) and Co-morbid Epilepsy
Learn more about:
Related Clinical Trial
A Controlled Trial of Growth Hormone in Phelan-McDermid Syndrome and Idiopathic Autism
Effectiveness of Recombinant Human Growth Hormone Therapy for Children With Phelan-McDermid Syndrome
An Open-Label Study of Oral NNZ-2591 in Phelan-McDermid Syndrome (PMS-001)
Clinical Trial in 22q13 Deletion Syndrome(Phelan-McDermid Syndrome)
Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome
Q10 Ubiquinol in Autism Spectrum Disorder and in Phelan-McDermid Syndrome.
AMO-01 to Treat Adolescents and Adults With Phelan-McDermid Syndrome (PMS) and Co-morbid Epilepsy
Growth Hormone Treatment in Children With Phelan McDermid Syndrome
Mitochondrial Dysfunction in Phelan-McDermid Syndrome: Explaining Clinical Variation and Providing a Path Towards Treatment
Mapping the Phenotype in Adults With Phelan-McDermid Syndrome
Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome